CEACAM based antibacterial agents
US12076365B2 · kind B2 · utility
0Cited by
8References
3Claims
0Family size
Inventor
Key dates
| Filing date | Sep 6, 2022 |
| Grant date | Sep 3, 2024 |
| Priority date | — |
| Expiry date | Sep 6, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Prophylactic and/or therapeutic antipathogen agents are provided that disrupt or prevent the formation of at least one homotypic and/or heterotypic protein-protein interaction that has at least one CEA-family protein and that is involved in the establishment and colonization of a pathogen in a suitable host.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.